Upload
isglobal
View
213
Download
1
Embed Size (px)
DESCRIPTION
This infographic highlights how some of the themes developed through the ISGlobal-University of Barcelona Master of Global Health.
Citation preview
7THINGSYOU’LL LEARN IN THE MASTER
OF GLOBAL HEALTH
SCHOOL, HOW WHETHER YOU GO TO
COULD HAVE JUST AS MUCH IMPACT ON YOUR HEALTH
THAT A GLOBAL ECONOMY MEANS THAT GLOBAL COOPERATION IS NEEDED TO FUND ESSENTIAL R&D:
DOCTOR AS WHETHER YOU GO TO THE
THAT CHRONIC ILLNESSES, LIKE CANCER AND HEART DISEASE, ARE NO LONGER JUST THE CONCERN OF HIGH-INCOME COUNTRIES
NUMB
ER O
F DE
ATHS
(MIL
LION
S)
30
25
20
15
10
5
0
GROUP III: Injuries
GROUP II: Other deaths from chronic non-communicable diseases
GROUP II: Premature deaths from non-communicble diseases (below the age of 60 years), which are preventable
GROUP I: Communicable diseases, maternal, perinatal and nutritional conditions
HIGH-INCOMECOUNTRIES
UPPER-MIDDLEINCOME-COUNTRIES
LOWER-MIDDLEINCOME-COUNTRIES
LOW-INCOMECOUNTRIES
5.9m
0.9m
3.0m
1.1m
10.2m
2.3m
3.3m
3.0m
2.3m
6.8m
3.7m
13.6m
OF GLOBAL INVESTMENT IN HEALTH R&D IS FOCUSED ON THE 90% OF THE GLOBAL BURDEN OF DISEASE
10%
90% OF GLOBAL INVESTMENT IN HEALTH R&D IS FOCUSED ON THE 10% OF THE GLOBAL BURDEN OF DISEASE
COMMUNICABLE DISEASES, LIKE MALARIA, TUBERCULOSIS AND HIV/AIDS,
ARE NOT JUST A PROBLEM OF THE SOUTH
THAT
THAT RIGOROUS RESEARCH, WHETHER QUANTITATIVE OR QUALITATIVE, IS A CORNERSTONE OFGLOBAL HEALTH
ESSENTIAL MANAGEMENT SKILLS ARE NOT JUST FOR BUSINESS STUDENTS -- THEY ARE NEEDED TO REACH OUR GLOBAL HEALTH GOALS
THAT
STRATEGIC PLANNING
ORGANISATION
PROJECT MANAGEMENT
LEADERSHIP TEAM-BUILDING
THAT EFFECTIVE HEALTH POLICIES AND STRATEGIES ALSO NEED A
STRONG POLITICAL WILL AND LEADERSHIP
WITH THE RIGHT TOOLS AND KNOWLEDGE, YOU CAN CONTRIBUTE TO THE WORLD-WIDE EFFORT TO SOLVE OUR MOST DIFFICULT GLOBAL
HEALTH CHALLENGES.JOIN US AT THE ISGLOBAL-UB MASTER
OF GLOBAL HEALTH!
NOEDUCATION
PRIMARYEDUCATION
LOWERSECONDARYEDUCATION
UPPERSECONDARYEDUCATION
POSTSECONDARYEDUCATION
DIST
RIBU
TION
(%)
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0
ADVOCACY + NETWORKING
KEY ACTORS AND STAKEHOLDERS
MOBILISATION AND FUNDS
Source: Karlsen et al. BMC Public Health 2011 11:606
Source: Geneau et al Lancet 2010;376:1689-98